Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes ; volume:15 ; number:1 ; day:10 ; month:7 ; year:2015 ; pages:1-13 ; date:12.2015
BMC cancer ; 15, Heft 1 (10.7.2015), 1-13, 12.2015
- Urheber
-
Khan, Faizan H.
- Beteiligte Personen und Organisationen
-
Pandian, Vijayabaskar
Ramraj, Satishkumar
Natarajan, Mohan
Aravindan, Sheeja
Herman, Terence S.
Aravindan, Natarajan
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1463-y
- URN
-
urn:nbn:de:1111-2016110616529
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Khan, Faizan H.
- Pandian, Vijayabaskar
- Ramraj, Satishkumar
- Natarajan, Mohan
- Aravindan, Sheeja
- Herman, Terence S.
- Aravindan, Natarajan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Allele-specific expression reveals genes with recurrent cis-regulatory alterations in high-risk neuroblastoma
Accumulation of potential driver genes with genomic alterations predicts survival of high-risk neuroblastoma patients
Genetic alterations and resectability predict outcome in patients with neuroblastoma assigned to high-risk solely by MYCN amplification
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
Gene expression signature of acquired chemoresistance in neuroblastoma cells
Dictate vom Kreistag
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines
Functional validation of novel target structures for treatment of high-risk neuroblastoma
Dictate über Ideal- und Naturphilosophie
Dictate von den Ulmer Kreistagen
Allele-specific expression reveals genes with recurrent cis-regulatory alterations in high-risk neuroblastoma
Accumulation of potential driver genes with genomic alterations predicts survival of high-risk neuroblastoma patients
Genetic alterations and resectability predict outcome in patients with neuroblastoma assigned to high-risk solely by MYCN amplification
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
Gene expression signature of acquired chemoresistance in neuroblastoma cells
Dictate vom Kreistag
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines
Functional validation of novel target structures for treatment of high-risk neuroblastoma
Dictate über Ideal- und Naturphilosophie
Dictate von den Ulmer Kreistagen
Allele-specific expression reveals genes with recurrent cis-regulatory alterations in high-risk neuroblastoma
Accumulation of potential driver genes with genomic alterations predicts survival of high-risk neuroblastoma patients
Genetic alterations and resectability predict outcome in patients with neuroblastoma assigned to high-risk solely by MYCN amplification
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
Gene expression signature of acquired chemoresistance in neuroblastoma cells
Dictate vom Kreistag
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines
Functional validation of novel target structures for treatment of high-risk neuroblastoma
Dictate über Ideal- und Naturphilosophie